Prevalence of intestinal metaplasia in the Helicobacter pylori-naive stomach

Prevalence of intestinal metaplasia in the Helicobacter pylori-naive stomach - Prevalence of intestinal metaplasia in the Helicobacter pylori-naive stomach

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045989

Enrollment

Registered

2021-11-08

Start date

2021-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal metaplasia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Negative for Helicobacter pylori infection. 2) Non-gastric mucosal atrophy on endoscopy. 3) Sporadic or regional mucosal abnormality related to gastritis. Then, biopsy is performed to rule out gastric cancer. 4) Over 20 year old. 5) Informed consent about this research has been obtained with participants in writing form.

Exclusion criteria

Exclusion criteria: 1) Difficult case to evaluate pathological features. 2) Patients with high risk of bleeding. 3) Inappropriate case for this research.

Design outcomes

Primary

Measure	Time frame
The incidence of intestinal metaplasia in gastritis-like lesion in the Helicobacter pylori-naive stomach.	—

Secondary

Measure	Time frame
1) The incidence of cancer in gastritis-like lesion in the Helicobacter pylori-naive stomach. 2) The difference in clinicopathological characteristics between patients with and without gastric intestinal metaplasia.	—

Countries

Japan

Contacts

Public ContactMaki Watanabe

Shimane University Hospital Gastroenterology

maki-w@med.shimane-u.ac.jp0853-20-2190

Outcome results